Board Of Directors

Dr. Y. K. Hamied

Non-Executive Chairman

Dr Y.K. Hamied is Non-Executive Chairman of the Company, and represents the second generation of Cipla’s founding family. A world-renowned scientist, Dr Hamied obtained his PhD in organic chemistry in 1960 from the University of Cambridge under the tutelage of the Nobel laureate Lord Alexander Todd.

Dr Y K Hamied is the Non-Executive Chairman of the Company. He represents the second generation of Cipla’s founding family. A world-renowned scientist, Dr Hamied obtained his PhD in Organic Chemistry in 1960 from the University of Cambridge under the tutelage of Nobel Laureate Lord Alexander Todd.

Dr Hamied has been an insightful R&D leader, a courageous industry captain, and an outspoken statesman of global pharma. From affordable drugs in HIV to enabling one of the world’s largest portfolio of drugs and devices in inhalation therapy, his pioneering work and immense contribution to healthcare have been celebrated around the world.

In 2005, Dr Hamied was conferred the Padma Bhushan by the Government of India for his distinguished service to the pharmaceutical industry. In 2013, he was named as one of India’s 25 Greatest Global Living Legends by NDTV, and in 2014, the University of Cambridge honoured him with a DSc the highest honour that the University can bestow. In 2017, Columbia University’s Mailman School of Public Health conferred the ‘Public Health Hero Award’ on Dr Hamied, and in 2018 India Today named him one of ‘20 Global Indians’ who have challenged convention and created history.

Dr Hamied has also been the recipient of several lifetime achievement awards. An Honorary Fellow of the Royal Society of Chemistry, Dr Hamied has frequent presence on high-level international panels on healthcare

Read More

Mr. M. K. Hamied

Non-Executive Vice-Chairman

Mr. M. K. Hamied is a science graduate from Bombay University and has vast and varied experience in all functions of the Company including production, technical areas, quality management and general administration.He is Non-Executive Vice-Chairman of the Company and represents the second generation of Cipla’s founding family.

Mr M K Hamied is the Non-Executive Vice-Chairman of the Company and represents the second generation of Cipla’s founding family. A science graduate from Bombay University, Mr Hamied has vast and varied experience in all functions of the Company including production, technical areas, quality management and general administration. He retired as Executive Vice-Chairman of the Company on 31st March, 2014; from 1st April, 2014, he has continued as the Non-Executive Vice-Chairman.

Read More

Ms. Samina Hamied

Non-Executive Director

Samina Hamied is an alumna of the London School of Economics. She has worked with the leading global firm Goldman Sachs (UK and US). Samina joined the Cipla leadership team in 2011 as Executive Director, and Global Head – Strategy, Cipla New Ventures.

Samina Hamied is an alumna of the London School of Economics. She has worked with the leading global firm Goldman Sachs (UK & US).

Samina joined the Cipla leadership team in 2011 as Executive Director, and Global Head – Strategy, M&A & Cipla New Ventures. She has been instrumental in driving the Company’s transformation agenda; playing a key role in successfully incubating Cipla’s consumer health business and spearheading the Company’s ambitious foray into the US market with strategic acquisitions. Samina has built a top-class leadership pipeline for the Company as it continues to spread its wings globally.

In her previous role as the Executive Vice-Chairperson of Cipla, Samina focused on board and governance issues, in addition to furthering Cipla’s strategic priorities through key global partnerships, corporate culture, hiring the right talent, and public advocacy. Samina also chaired the Inclusion & Diversity Council at Cipla.

Recognised as the third generation of the founding family, Samina has been feted for her diverse work experience and business knowledge. She was amongst Business Today’s ‘Most Powerful Women in Business’ in 2017 & 2022. In 2018, Forbes featured Samina in the ‘Top 25 Emergent Women Business Leaders in Asia’. Fortune India named her amongst the ‘Most Powerful Women in Business for five consecutive years (2018-2022). She was awarded ‘Businesswoman of the Year’ at The Economic Times Awards for Corporate Excellence in 2021. Most recently, Samina was conferred the ‘EY Entrepreneur of the Year 2022’ in life sciences and healthcare category; and was named among the ‘Most Influential Women in Healthcare 2023’ by BW Healthcare World.

Read More

Mr. Umang Vohra

Managing Director & Global Chief Executive Officer

Umang Vohra is Managing Director and Global Chief Executive Officer (MD and GCEO) of Cipla since September 2016. Umang joined Cipla in October 2015 as its Global Chief Financial Officer, and from January 2016 to August 2016 was Cipla’s Global Chief Operating Officer.

Mr Umang Vohra joined Cipla Limited in 2015 and has been the MD & GCEO of the Company since September 2016. After gaining degrees in engineering, marketing and finance, Mr Vohra worked with Eicher Motors, PepsiCo and Dr Reddy’s Laboratories. Through his previous roles in India and the US, he has built a distinguished career spanning almost two decades with deep understanding and experience of various aspects of the global pharmaceutical business.

As Cipla’s MD & GCEO, Mr Vohra’s priorities have been Cipla’s strategic growth, defining and executing Cipla’s roadmap to maintain momentum in home markets whilst strengthening its presence in other regions, consolidating its core focus areas, augmenting capability, and building the right organisation. Recognised as an action-oriented industry leader, Mr Vohra is a firm believer in the power of agile business models, disruptive technologies, data-driven analytics and a future-ready workforce with a view to making a difference to the lives of patients.

Read More

Mr. S. Radhakrishnan

Non-Executive Director

Mr S. Radhakrishnan is a Non-Executive Director of the Company and is a qualified Chartered Accountant. He possesses rich experience in financial, commercial, legal and allied areas.

A qualified chartered accountant, Mr S. Radhakrishnan is a Non-Executive Director of the Company. He possesses rich experience in financial, commercial, legal and allied areas. He has been with Cipla for over 37 years and has played a pivotal role in the overall journey and growth of the organisation. Mr S Radhakrishnan retired from his position of Whole-Time Director in November 2017 and thereafter continues as a Non-Executive Director of the Company.

Read More

Mr. Ashok Sinha

Independent Director

Mr Ashok Sinha is an Independent Non-Executive Director of the Company. He has a B.Tech. degree in Electrical Engineering from the Indian Institute of Technology (IIT), Kanpur and Post Graduate Diploma in Management from the Indian Institute of Management (IIM), Bangalore with specialisation in Finance.

Mr Ashok Sinha is an Independent Non-Executive Director of the Company. He has a BTech in Electrical Engineering from the Indian Institute of Technology (IIT), Kanpur, and a Post Graduate Diploma in Management from the Indian Institute of Management (IIM), Bangalore, with specialisation in Finance.

He has been conferred with the distinguished alumnus award from both IIT Kanpur and IIM Bangalore. He has also been conferred with the India Chief Financial Officer Award 2001 for Information and Knowledge Management by the Economic Intelligence Unit (EIU) India and American Express. He is also a recipient of award from TMG (Technology Media Group) for Customer Management.

Mr Sinha has a wealth of experience, competencies and expertise from his leadership journey as the Chairman and Managing Director of Bharat Petroleum Corporation Ltd. (BPCL). He spent 33 years in BPCL and served on the Board of BPCL for 15 years – first as Director (Finance) for 10 years from 1996 and then as its Chairman and Managing Director for 5 years from August 2005.

Read More

Mr. Adil Zainulbhai

Independent Director

Mr Adil Zainulbhai is an Independent Non-Executive Director and Lead Independent Director of the Company. He is the Chairman of the Quality Council of India (QCI) and Board Advisor to US India strategic partnership forum.

Mr Adil Zainulbhai is an Independent Non-Executive Director and the Lead Independent Director of the Company. He is the Chairman of the Quality Council of India (QCI) and Board Advisor to the US India strategic partnership forum. He is also on the Board of Reliance Industries, Larsen & Toubro as well as the Chairman of Network18 Media and Investment Limited and TV18 Broadcast Limited. He is involved in many philanthropic causes and is also on the Board of Piramal Foundation.

Mr Zainulbhai graduated in Mechanical Engineering from the Indian Institute of Technology. He also has an MBA from Harvard Business School. He retired as Chairman of McKinsey, India after 34 years at McKinsey, the last ten were in India. Prior to returning to India, he led the Washington office of McKinsey and founded its Minneapolis office.

Mr Zainulbhai co-edited the book, ‘Reimagining India’ which featured 60 authors including prominent businessmen, academics, economists, authors and journalists.

Read More

Mr. P. R. Ramesh

Independent Director

Mr P. R. Ramesh graduated in Commerce from Osmania University, Hyderabad and is a Fellow Member of the ICAI. He retired as the Director of Deloitte & Touche Assurance & Enterprise Risk Services India on 31st March 2020 and has also served as a member of Deloitte Global Board and Deloitte Asia Pacific Board.

Mr P. R. Ramesh graduated in Commerce from Osmania University, Hyderabad and is a Fellow Member of the ICAI. He retired as the Director of Deloitte & Touche Assurance & Enterprise Risk Services India on 31st March 2020 and has also served as a member of Deloitte Global Board and Deloitte Asia Pacific Board. Ramesh has over 40 years of professional experience across manufacturing, banking and financial services, technology, media, telecommunications, energy and resources and consumer business sectors. He has been associated with various Regulatory bodies such as SEBI Committee on Disclosures and Accounting Standards; Committee for Reforming the Regulatory Environment for doing Business in India; Technical Committee to review the form and presentation of the Balance Sheet of the RBI; IRDA Standing Committee on Accounting Issues and Invitee to the Committee set up by the RBI to assist in convergence to IFRS by banks and National Advisory Committee on Accounting Standards. He has been associated with various Industry Bodies such as CII representing on its National Council, Committee on Financial Reporting and its CFO Forum; National Executive Committee of FICCI and Past President of the of the Bombay Chamber of Commerce & Industry. He has also been member of Accounting Standards Board of ICAI, Vision and Restructuring Committee and Auditing Practices Committee of ICAI and the Secretarial Standards Boards of the ICSI. He has co-authored publication by CCH titled iGAAP – Financial Reporting Standards in India including a comparison with IFRS and is a member of Board of Studies and the Faculty of Commerce of Osmania University.

Read More

Ms. Punita Lal

Independent Director

Ms Punita Lal is an Independent Non-Executive Director of the Company. She is a B.A. (Hons.) Economics graduate from St. Stephen’s College, Delhi and an MBA from Indian Institute of Management, Kolkata.

Ms Punita Lal is an Independent Non-Executive Director of the Company. She has 30 years of experience in strategy, marketing and leadership in the corporate world across Asia, spanning multiple disciplines, geographies and cultures. Ms Lal has a BA(Hons) in Economics from St Stephen’s College, Delhi and an MBA from the Indian Institute of Management, Kolkata.

As a senior business leader, she has many accolades to her credit, including being chosen as one of India’s top 20 Businesswomen by Business Today in 2006, and being awarded Corporate Woman of the Year in 2009 by the FICCI Women’s Organisation. She is currently practising as an Independent Strategy and Marketing Consultant.

Read More

Mr. Robert Stewart

Independent Director

Robert Stewart is an Independent Non-Executive Director of the Company. He has over 34 years of experience in the biopharmaceutical industry having worked with leading companies such as Roche, Abbott, Watson / Actavis / Allergan, Amneal and Theramex. Currently, Robert is the Chief Executive Officer at Theramex Ltd, a global specialty pharmaceutical company.

Robert Stewart is an Independent Non-Executive Director of the Company.

He has over 34 years of experience in the biopharmaceutical industry having worked with leading companies such as Roche, Abbott, Watson / Actavis / Allergan, Amneal and Theramex. Currently, Robert is the Chief Executive Officer at Theramex Ltd, a global specialty pharmaceutical company.

Robert has deep expertise in manufacturing operations, quality, supply chain and general management and a very strong exposure to commercial operations. He has served on the boards of several industry and non-profit organizations and served for nearly two years on the Amneal board of directors.

Robert has a B.S., Business Management from Fairleigh Dickinson University, New Jersey.

Read More

Dr. Mandar Vaidya

Independent Director

Dr. Mandar is a medical doctor, and a management graduate from the Jamnalal Bajaj Institute of Management Studies, India.

Dr. Mandar is a medical doctor, and a management graduate from the Jamnalal Bajaj Institute of Management Studies, India.

Mandar spent 15 years at McKinsey (2002-2017), the last seven as partner where he co-led the healthcare practice in India and established the Hospitals practice for Asia. He served leading pharmaceutical companies across India and globally across several areas such as core strategy, manufacturing productivity improvement, R&D productivity, portfolio management, M&A and procurement programs.

From 2017 to 2019 Mandar worked part time advising several healthcare companies, providing leadership coaching and designing and teaching a course on problem solving at Ashoka University.

In Aug 2019, Mandar joined global travel-tech company OYO as CEO – SE Asia & Middle East, driving growth, doubling the number of hotels and homes, while transforming the regions contribution margin to a net positive territory. He led the business through the COVID crisis, improving EBIDTA loss to a negligible level while manging massive business disruptions.

Since March 2021 Mandar is the CEO - OYO Vacation Homes (OVH), Europe, a strategically important core market for the company. OVH is Europe's second largest vacation homes company. Mandar leads three acquired brands, DanCenter, Belvilla and Traum FW, each with a multi decade legacy. He has turbo charged their growth and profitability by migrating them into a tech forward environment while retaining the uniqueness of each businesses bult over the last several decades.

Mandar grew up in Mumbai, but now lives in Gurgaon with his wife and 3-year-old son. He enjoys spending time with his friends, watching movies, and trying out his hand at new pursuits, especially outdoors.

Read More

Dr. Balram Bhargava

Additional and Independent Director

Dr. Balram Bhargava is a global public health leader. Mission-driven, results-oriented health professional with more than 35 years of experience

Dr. Balram Bhargava is a global public health leader. Mission driven, results oriented health professional with more than 35 years of experience in leading medical research, strengthening health systems, health care innovation, managing pandemic preparedness and health care delivery in resource poor settings. As a global leader he has been in the forefront of south-south cooperation, promoting equity in access to health care, democratisation of scientific research and promoting public-private cooperation to bring new technologies and affordable innovative products into the health systems.

He has led India’s Department of Health Research as its Secretary and Director-General of the Indian Council of Medical Research. He is also a Professor of Cardiology at the All-India Institute of Medical Sciences, New Delhi and serves as the Executive Director for Stanford India Biodesign Centre, School of International Biodesign (SiB). An extensively published scientist with more than 300 articles in peer reviewed journals and editor-in-chief of the British Medical Journal Innovations and of the Indian Journal of Medical Research.

His experience ranges from treating more than a quarter million patients, training and mentoring super specialised cardiologists to setting health care policies and standards and advising several Ministers of Health and Heads of Government. In recent years he has been at the forefront of managing several public health crises in India including covid-19 and brought Indian research in shaping contemporary global practice through vaccine development and describing role of plasma therapy. He has also received numerous international and national awards for his contributions to health and development and has delivered more than 50 orations across the globe. He has international experience of more than 6 years in the USA, Europe and the Middle East.

Read More
Dr. Y. K. Hamied

Dr. Y. K. Hamied

Non-Executive Chairman

Mr. M. K. Hamied

Mr. M. K. Hamied

Non-Executive Vice-Chairman

Ms. Samina Hamied

Ms. Samina Hamied

Non-Executive Director

Mr. Umang Vohra

Mr. Umang Vohra

Managing Director & Global Chief Executive Officer

Mr. S. Radhakrishnan

Mr. S. Radhakrishnan

Non-Executive Director

Mr. Ashok Sinha

Mr. Ashok Sinha

Independent Director

Mr. Adil Zainulbhai

Mr. Adil Zainulbhai

Independent Director

Mr. P. R. Ramesh

Mr. P. R. Ramesh

Independent Director

Ms. Punita Lal

Ms. Punita Lal

Independent Director

Mr. Robert Stewart

Mr. Robert Stewart

Independent Director

Dr. Mandar Vaidya

Dr. Mandar Vaidya

Independent Director

Dr. Balram Bhargava

Dr. Balram Bhargava

Additional and Independent Director